[Evaluation of the efficacy of chelation therapy with deferoxamine in patients with thalassemia major].
Rodríguez Galindo C(Universitat Autònoma de Barcelona), Pilar Bastida, Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Jaume Casaldáliga, T Olivé(Hospital Materno-Infantil), Alonso Martínez Jl, J J Ortega Aramburu, Marián Albisu
PubMed
May 21, 1994
Cited by 3
Related Papers
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
|Haematologica|2014|389
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
|Journal of Clinical Oncology|2020|333
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
|Journal of Allergy and Clinical Immunology|2017|318